Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06766279 · ClinicalTrials.gov registry record · NA
Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19
A NA study of Anosmia, sponsored by Burrell College of Osteopathic Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06766279: Recruiting NA study of Anosmia, sponsored by Burrell College of Osteopathic Medicine.
NCT06766279 is a NA study of Anosmia that is actively recruiting participants, run by Burrell College of Osteopathic Medicine. The registered enrollment target is 32 participants, below the 238-participant average among 5 other Anosmia trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06766279, a NA study of Anosmia, is actively recruiting participants, sponsored by Burrell College of Osteopathic Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
One of the most widespread symptoms of COVID-19 is loss of the sense of smell. There are very few treatments for helping individuals recover their sense of smell. Osteopathic manipulative treatment (OMT) may be a useful tool in helping people recover their smell perception. In this study the investigators test whether OMT can be used to help individuals recover their sense of smell if they lost it during COVID-19.
Primary Outcome
Data from 32 COVID-19-positive individuals will be collected. This group will be divided into 2 groups of 16: one of these groups will be given the OMT intervention, and one will be given a sham intervention. The sample size of 16 per group comes about as follows. The main dependent variable measured for each person will be the number of odors identified out of a panel of 16 odors. This will be in the form of a multiple-forced-choice questionnaire: participants will be required to identify the o
Conditions Studied
Interventions
- PROCEDURE Osteopathic Manipulative Treatment
- PROCEDURE Sham treatment
Study Locations (1)
New Mexico
- Burrell College of Osteopathic Medicine - Las Cruces
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-08-29 |
| Est. Completion | 2025-08 |
| Phase | NA |
What NCT06766279 shows while recruiting
NCT06766279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 238-participant average among 5 other Anosmia trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Anosmia appearing as the primary indexed condition, and to 2 interventions - of which Osteopathic Manipulative Treatment is the first listed.
NCT06766279 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT06766279 about?
NCT06766279 is a clinical study titled "Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19". One of the most widespread symptoms of COVID-19 is loss of the sense of smell. There are very few treatments for helping individuals recover their sense of smell. Osteopathic manipulative treatment (OMT) may be a useful tool in helping people recover their smell perception. In this study the investi...
What is the current status of trial NCT06766279?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-08-29. Estimated completion is 2025-08.
What conditions does trial NCT06766279 study?
This clinical trial studies the following conditions: Anosmia.
What interventions are being tested in trial NCT06766279?
The interventions under investigation include: Osteopathic Manipulative Treatment (PROCEDURE), Sham treatment (PROCEDURE).
Who is sponsoring clinical trial NCT06766279?
This trial is sponsored by Burrell College of Osteopathic Medicine, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06766279 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anosmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults
RECRUITING · NA
-
Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery
COMPLETED · NA
-
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
ACTIVE NOT RECRUITING
-
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
ACTIVE NOT RECRUITING · Phase 2
-
Smell Changes & Efficacy of Nasal Theophylline
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI